50% OF ALL NDAs SUPPORTED SINCE 2014

NEWS AND MEDIA

See what we’re up to – and what we have to say – in today’s dynamic market.

All NEWS/MEDIA




Five Reasons to Embrace the ICH E6 (R2) Addendum Now

This article reviews how, by adopting the guidelines set out in ICH E6(R2), sponsors can improve study efficiencies by centralizing risk-based quality oversight and trial management.

Share



What are you Wearing?

Thinking about using wearable devices (activity trackers, smart watches, etc.) in clinical trials? Read this article that outlines the scientific and operational factors to consider…

Share



ERT Acquires Exco InTouch

Combination delivers end-to-end eCOA, patient engagement and digital health solutions to better serve customers. Read More.

Share








ERT Bolsters Data Leadership

Chief Data Officer enhances delivery of high quality data reporting in clinical development. Read more.

Share






ERT Takes the Headache out of Migrane Drug Study

ERT eCOA diaries and solution delivery enable CoLucid Pharmaceuticals to collect quality data, on time, while minimizing study complexity and risk. Read More.

Share